Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Head, US Ozempic® Commercialization, Diabetes Marketing at Novo Nordisk
Jeremy is currently responsible for the US commercialization and launch of Ozempic, a GLP-1 for Type 2 diabetes and a top 3 drug launches in 2018. Prior to that he lead Patient Centric Marketing across the portfolio where he was responsible for championing patient centricity throughout NNI, ensuring collective actions and decisions enhance patient outcomes and drive top/bottom line growth: POSITIVE OUTCOME, POSITIVE INCOME.
Among his many accomplishments was the successful launches of the first-in-class Diabetes Health Coach (a highly immersive and personalized behavioral modification program) and the YouTube channel The Diabetes Download. Before joining Novo Nordisk, Jeremy’s time in product marketing experience was spent in small/medium pharma organizations, where smaller budgets and aggressive sales targets required marketers to think “out of the box” while highly scrutinizing their marketing investments. Jeremy holds a B.S. in from Bentley University.